| 000 | 01702 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515071844.0 | ||
| 264 | 0 | _c20071029 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a0020-7136 | ||
| 024 | 7 |
_a10.1002/ijc.22886 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDevalapally, Harikrishna | |
| 245 | 0 | 0 |
_aPaclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cOct 2007 |
||
| 300 |
_a1830-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBiocompatible Materials _xadministration & dosage |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCeramides _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aNanoparticles _xadministration & dosage |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aPolyesters _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTransplantation, Heterologous |
| 700 | 1 | _aDuan, Zhenfeng | |
| 700 | 1 | _aSeiden, Michael V | |
| 700 | 1 | _aAmiji, Mansoor M | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 121 _gno. 8 _gp. 1830-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ijc.22886 _zAvailable from publisher's website |
| 999 |
_c17096004 _d17096004 |
||